vs
Side-by-side financial comparison of Sight Sciences, Inc. (SGHT) and Snail, Inc. (SNAL). Click either name above to swap in a different company.
Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $20.4M, roughly 1.2× Sight Sciences, Inc.). Snail, Inc. runs the higher net margin — -3.4% vs -20.4%, a 17.0% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -4.2%). Over the past eight quarters, Snail, Inc.'s revenue compounded faster (33.4% CAGR vs 2.9%).
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....
SGHT vs SNAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.4M | $25.1M |
| Net Profit | $-4.2M | $-862.2K |
| Gross Margin | 87.3% | 38.3% |
| Operating Margin | -18.0% | -6.0% |
| Net Margin | -20.4% | -3.4% |
| Revenue YoY | 6.9% | -4.2% |
| Net Profit YoY | 64.9% | -177.0% |
| EPS (diluted) | $-0.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.4M | $25.1M | ||
| Q3 25 | $19.9M | $13.8M | ||
| Q2 25 | $19.6M | $22.2M | ||
| Q1 25 | $17.5M | $20.1M | ||
| Q4 24 | $19.1M | $26.2M | ||
| Q3 24 | $20.2M | $22.5M | ||
| Q2 24 | $21.4M | $21.6M | ||
| Q1 24 | $19.3M | $14.1M |
| Q4 25 | $-4.2M | $-862.2K | ||
| Q3 25 | $-8.2M | $-7.9M | ||
| Q2 25 | $-11.9M | $-16.6M | ||
| Q1 25 | $-14.2M | $-1.9M | ||
| Q4 24 | $-11.8M | $1.1M | ||
| Q3 24 | $-11.1M | $235.1K | ||
| Q2 24 | $-12.3M | $2.3M | ||
| Q1 24 | $-16.3M | $-1.8M |
| Q4 25 | 87.3% | 38.3% | ||
| Q3 25 | 86.4% | 0.1% | ||
| Q2 25 | 84.8% | 31.3% | ||
| Q1 25 | 86.2% | 29.1% | ||
| Q4 24 | 86.8% | 43.3% | ||
| Q3 24 | 83.9% | 38.6% | ||
| Q2 24 | 85.8% | 37.5% | ||
| Q1 24 | 85.5% | 14.7% |
| Q4 25 | -18.0% | -6.0% | ||
| Q3 25 | -39.7% | -71.3% | ||
| Q2 25 | -59.6% | -8.2% | ||
| Q1 25 | -79.2% | -20.4% | ||
| Q4 24 | -62.5% | 11.5% | ||
| Q3 24 | -55.7% | 1.8% | ||
| Q2 24 | -59.2% | 12.4% | ||
| Q1 24 | -76.4% | -15.6% |
| Q4 25 | -20.4% | -3.4% | ||
| Q3 25 | -41.0% | -56.9% | ||
| Q2 25 | -61.0% | -74.7% | ||
| Q1 25 | -80.8% | -9.7% | ||
| Q4 24 | -62.1% | 4.3% | ||
| Q3 24 | -54.9% | 1.0% | ||
| Q2 24 | -57.7% | 10.4% | ||
| Q1 24 | -84.4% | -12.6% |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.23 | $-0.44 | ||
| Q1 25 | $-0.28 | $-0.06 | ||
| Q4 24 | $-0.23 | $0.03 | ||
| Q3 24 | $-0.22 | $0.01 | ||
| Q2 24 | $-0.25 | $0.06 | ||
| Q1 24 | $-0.33 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $92.0M | $8.6M |
| Total DebtLower is stronger | $42.4M | $14.6M |
| Stockholders' EquityBook value | $63.9M | $-16.4M |
| Total Assets | $115.3M | $59.3M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $92.0M | $8.6M | ||
| Q3 25 | $92.4M | $12.3M | ||
| Q2 25 | $101.5M | $7.9M | ||
| Q1 25 | $108.8M | $9.4M | ||
| Q4 24 | $120.4M | $7.3M | ||
| Q3 24 | $118.6M | $10.6M | ||
| Q2 24 | $118.2M | $15.5M | ||
| Q1 24 | $127.3M | $16.1M |
| Q4 25 | $42.4M | $14.6M | ||
| Q3 25 | $42.4M | $10.5M | ||
| Q2 25 | $42.4M | $11.8M | ||
| Q1 25 | $42.4M | $9.0M | ||
| Q4 24 | $40.0M | $5.7M | ||
| Q3 24 | $37.1M | $5.7M | ||
| Q2 24 | $35.0M | $5.8M | ||
| Q1 24 | $35.0M | $6.5M |
| Q4 25 | $63.9M | $-16.4M | ||
| Q3 25 | $64.3M | $-15.6M | ||
| Q2 25 | $70.0M | $-8.0M | ||
| Q1 25 | $77.6M | $9.1M | ||
| Q4 24 | $87.5M | $9.7M | ||
| Q3 24 | $95.0M | $8.2M | ||
| Q2 24 | $101.6M | $7.9M | ||
| Q1 24 | $109.2M | $5.6M |
| Q4 25 | $115.3M | $59.3M | ||
| Q3 25 | $116.3M | $51.1M | ||
| Q2 25 | $122.0M | $58.0M | ||
| Q1 25 | $129.7M | $64.5M | ||
| Q4 24 | $142.8M | $62.2M | ||
| Q3 24 | $143.6M | $66.8M | ||
| Q2 24 | $149.7M | $75.4M | ||
| Q1 24 | $155.6M | $78.3M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.55× | 0.99× | ||
| Q4 24 | 0.46× | 0.59× | ||
| Q3 24 | 0.39× | 0.70× | ||
| Q2 24 | 0.34× | 0.73× | ||
| Q1 24 | 0.32× | 1.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.8M | $-5.3M |
| Free Cash FlowOCF − Capex | $-2.0M | — |
| FCF MarginFCF / Revenue | -9.7% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.8M | $-5.3M | ||
| Q3 25 | $-8.7M | $6.6M | ||
| Q2 25 | $-7.5M | $-3.2M | ||
| Q1 25 | $-11.6M | $764.5K | ||
| Q4 24 | $-3.5M | $-3.6M | ||
| Q3 24 | $362.0K | $-5.0M | ||
| Q2 24 | $-9.5M | $206.6K | ||
| Q1 24 | $-9.8M | $6.8M |
| Q4 25 | $-2.0M | — | ||
| Q3 25 | $-8.9M | — | ||
| Q2 25 | $-7.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $311.0K | — | ||
| Q2 24 | $-9.5M | — | ||
| Q1 24 | $-9.9M | — |
| Q4 25 | -9.7% | — | ||
| Q3 25 | -44.7% | — | ||
| Q2 25 | -39.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -18.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | -44.7% | — | ||
| Q1 24 | -51.4% | — |
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.21× | ||
| Q3 24 | — | -21.05× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |
